menu ☰
menu ˟

NICE says yes to non-Hodgkin?s lymphoma treatment in final draft guidance

01 Jan 2014
Draft guidance from NICE says the drug pixantrone should be funded by the NHS to treat certain people with aggressive non-Hodgkin?s B-cell lymphoma. ...

Click here to view the full article which appeared in National Institute for Health and Clinical Excellence (NICE)

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.